• Shares of protein discovery platform Absci pop in market debut

    3 days ago - By Tech Crunch

    Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It's another sign of snowballing interest in new approaches to drug development - a traditionally risky business.
    Absci focuses on speeding drug development in the preclinical stages. The company has developed and acquired a handful of tools that can predict drug candidates, identify potential therapeutic targets, and test therapeutic proteins on billions of cells and identify which ones are worth pursuing.
    “We are offering a fully-integrated end-to-end solution for pharmaceutical...
    Read more ...